Detalhe da pesquisa
1.
[Prognostic Factors of Stage 3 Colorectal Cancer in 433 Patients].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 37(5): 549-56, 2015 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-26564506
2.
Regulatory T cells increase in breast cancer and in stage IV breast cancer.
Cancer Immunol Immunother
; 61(6): 911-6, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22116346
3.
[Expressions of human epidermal growth factor receptor 2 and vascular endothelial growth factor in primary or recurrent metastatic breast cancers].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 32(4): 403-6, 2010 Aug.
Artigo
em Zh
| MEDLINE | ID: mdl-20868598
4.
Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis.
Oncotarget
; 8(39): 66550-66558, 2017 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29029535
5.
KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients.
Sci Rep
; 7(1): 14368, 2017 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29085005
6.
Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma.
Onco Targets Ther
; 6: 585-91, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23737672
7.
[Thymidylate synthase expression and therapeutic effect analysis of pemetrexed in advanced lung adenocarcinoma].
Nan Fang Yi Ke Da Xue Xue Bao
; 30(5): 978-80, 2010 May.
Artigo
em Zh
| MEDLINE | ID: mdl-20501373